Eastern Bank’s West Pharmaceutical WST Stock Holding History

Eastern Bank’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$158K	Sell	427 -3	-0.7%	-$1.06K	﹤0.01%	432
2026 Q2	$154K	Buy	430 +157	+58%	+$48K	﹤0.01%	428
2026 Q1	$68.4K	Hold	273	–	–	﹤0.01%	522
2025 Q4	$75.1K	Hold	273	–	–	﹤0.01%	507
2025 Q3	$71.6K	Hold	273	–	–	﹤0.01%	503
2025 Q2	$59.7K	Hold	273	–	–	﹤0.01%	523
2025 Q1	$61.1K	Hold	273	–	–	﹤0.01%	524
2024 Q4	$89.4K	Hold	273	–	–	﹤0.01%	486
2024 Q3	$81.9K	Buy	+273	New	+$83.6K	﹤0.01%	492

Other funds holding WST

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return

AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

North Growth Management Vancouver, British Columbia, Canada $743M AUM 74.29% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Eastern Bank's WST Position: Q3 2026 in Review

Eastern Bank reduced its West Pharmaceutical (WST) stake by 0.7% in Q3 2026, selling an estimated $1.06K and leaving 427 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #432.

Eastern Bank first reported a position in WST in Q3 2024 and has held it in 9 quarters since. 175 funds tracked by Wall St. Rank hold WST as of Q3 2026.

Eastern Bank held 427 shares of West Pharmaceutical worth $158K as of Q3 2026.
Eastern Bank sold 3 West Pharmaceutical shares in Q3 2026, an estimated $1.06K.
West Pharmaceutical made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #432 holding.
Eastern Bank first reported a position in West Pharmaceutical in Q3 2024 and has held it in 9 quarters since.
175 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.